PDL BioPharma Inc (NASDAQ:PDLI) - Share price - Overview

Stock Report

PDL BioPharma Inc PDLI

Last Price
$2.22

Day Change
-0.05|-2.20%

As of 21/02/2017
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close2.27
Day Range2.21 - 2.31
Mkt Cap367.50Mil
52-Wk Range1.93 - 3.84
Yield %4.50
ISINUS69329Y1047
Volume1,440,162
P/E2.09
P/S1.02
P/CF2.33

Share Price

Financials
201320142015
More ...
Income Statement
Revenue442.92581.23590.45
Operating Income407.53546.31550.38
Net Income264.53322.24332.80
Basic EPS1.892.042.04
Avg. Diluted Shares Outstanding159173164
Balance Sheet
Current Assets107.70355.90282.71
Non Current Assets436.26606.45733.47
Total Assets543.96962.351,016.18
Current Liabilities407.42187.9836.74
Total Liabilities430.47501.91320.23
Total Equity113.49460.44695.95
Cash Flow
Operating Cash Flow270.89292.28301.47
Capital Expenditure-241.32-81.15-115.01
Free Cash Flow29.57211.13186.46

In millions, except "Basic EPS". Currency is USD.

Company Profile

PDL BioPharma Inc is engaged in the discovery of a new generation of targeted treatments for cancer & immunologic diseases. It focuses on intellectual property asset management, investing in new royalty bearing assets & maximizing value of its patent.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

11
Key Stats
More ...
Price/Earning TTM2.12
Price/Book0.50
Price/Sales TTM1.04
Rev Growth (3 year avg)16.39
EPS Growth (3 year avg)-
Operating Margin % TTM93.21
Net Margin % TTM56.36
ROE TTM57.56
Debt/Equity0.33
Dividends
PreviousLatest
More ...
Declared Date01/02/1602/05/16
Ex-Div02/03/1602/06/16
Paid11/03/1613/06/16
Amnt0.050.05
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.